1.Calcium/Calmodulin Kinase II Activity of Hippocampus in Kainate-Induced Epilepsy.
Min Cheol LEE ; Sung Soo BAN ; Young Jong WOO ; Seung U KIM
Journal of Korean Medical Science 2001;16(5):643-648
This study investigated calcium/calmodulin kinase II (CaMKII) activity related to long-standing neuronal injury of the hippocampus in kainate (KA)-induced experimental temporal lobe epilepsy. Epileptic seizure was induced by injection of KA (1 g/L) dissolved in phosphate buffer (0.1 M, pH 7.4) into the left amygdala. Clinical seizures, histopathologic changes and CaMKII activity of the hippocampus were evaluated. Characteristic early limbic and late seizures were developed. Hippocampal CaMKII activity increased significantly 4 and 8 weeks after intra-amygdaloid injection of KA, when late seizures developed. The histopathologic changes of the hippocampus included swelling of neuronal cytoplasm with nuclear pyknosis and loss of neurons in CA3 during this period. The increased activity of CaMKII may correlate with appearance of distant damage in the hippocampus. The above results indicate that intra-amygdaloid injection of KA produces excitatory signals for ipsilateral CA3 neurons in the hippocampus and that subsequently increased levels of CaMKII in postsynaptic neurons induce neuronal injury via phosphorylation of N-methyl-D-aspartate type glutamate receptor.
Animal
;
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism
;
Epilepsy, Temporal Lobe/chemically induced/*enzymology/pathology
;
Hippocampus/*enzymology/pathology
;
Kainic Acid/*toxicity
;
Long-Term Potentiation/drug effects
;
Male
;
Rats
;
Rats, Wistar
2.Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells.
Chi Dug KANG ; In Rok DO ; Kwang Woon KIM ; Byung Kwon AHN ; Sun Hee KIM ; Byung Seon CHUNG ; Byung Hak JHUN ; Mi Ae YOO
Experimental & Molecular Medicine 1999;31(2):76-82
The chronic myelogenous leukemic K562 cell line carrying Bcr-Abl tyrosine kinase is considered as pluripotent hematopoietic progenitor cells expressing markers for erythroid, granulocytic, monocytic, and megakaryocytic lineages. Here we investigated the signaling modulations required for induction of erythroid differentiation of K562 cells. When the K562 cells were treated with herbimycin A (an inhibitor of protein tyrosine kinase), ras antisense oligonucleotide, and PD98059 (a specific inhibitor of MEK), inhibition of ERK/MAPK activity and cell growth, and induction of erythroid differentiation were observed. The ras mutant, pZIPRas61leu-transfected cells, K562-Ras61leu, have shown a markedly decreased cell proliferation rate with approximately 2-fold doubling time, compared with the parental K562 cells, and about 60% of these cells have shown the phenotype of erythroid differentiation. In addition, herbimycin A inhibited the growth rate and increased the erythroid differentiation, but did not affect the elevated activity of ERK/MAPK in the K562-Ras61leu cells. On the other hand, effects of PD98059 on the growth and differentiation of K562-Ras61leu cells were biphasic. At low concentration of PD98059, which inhibited the elevated activity of ERK/MAPK to the level of parental cells, the growth rate increased and the erythroid differentiation decreased slightly, and at high concentration of PD98059, which inhibited the elevated activity of ERK/MAPK below that of the parental cells, the growth rate turned down and the erythroid differentiation was restored to the untreated control level. Taken together, these results suggest that an appropriate activity of ERK/MAPK is required to maintain the rapid growth and transformed phenotype of K562 cells.
Androstadienes/pharmacology
;
Ca(2+)-Calmodulin Dependent Protein Kinase
;
Cell Differentiation/drug effects
;
Enzyme Inhibitors/pharmacology
;
Erythroid Progenitor Cells/physiology*
;
Erythroid Progenitor Cells/cytology
;
Erythropoiesis*
;
Flavones/pharmacology
;
Human
;
K562 Cells
;
Leukemia, Myeloid/pathology
;
Oligonucleotides, Antisense/pharmacology
;
Quinones/pharmacology
;
ras Proteins/metabolism*
3.Increased expression of Galphaq protein in the heart of streptozotocin-induced diabetic rats.
Jung Mee YANG ; Chin Ho CHO ; Kyoung Ae KONG ; Ik Soon JANG ; Hae Won KIM ; Yong Sung JUHNN
Experimental & Molecular Medicine 1999;31(4):179-184
Heart disease is one of the major cause of death in diabetic patients, but the thogenesis of diabetic cardio-myopathy remains unclear. In this experiment, to sess the significance of G protein signaling pathways in the pathogenesis of abetic cardiomyopathy, we analyzed the expression of G proteins and the tivities of second messenger dependent protein kinases: cAMP-dependent protein nase (PKA), DAG-mediated protein kinase C (PKC), and calmodulin dependent otein kinase II (CaM kinase II) in the streptozotocin induced diabetic rat art. The expression of Galphaq was increased by slightly over 10% (P<0.05) in abetic rat heart, while Galphas, Galphai, and Gbeta remained unchanged. The A activity in the heart did not change significantly but increased by 27%<0.01) in the liver. Insulin treatment did not restore the increased activity the liver. Total PKC activity in the heart was increased by 56% (P<0.01), and sulin treatment did not restore such increase. The CaM kinase II activity in e heart remained at the same level but was slightly increased in the liver 4% increase, P<0.05). These findings of increased expression of Galphaq in the reptozotocin-diabetic rat heart that are reflected by the increased level of C activity and insensitivity to insulin demonstrate that alteration of Galphaq y underlie, at least partly, the cardiac dysfunction that is associated with abetes. Copyright 2000 Academic Press.
Animal
;
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism
;
Cyclic AMP-Dependent Protein Kinases/metabolism
;
Diabetes Mellitus, Experimental/metabolism*
;
Diabetes Mellitus, Experimental/drug therapy
;
Diabetes Mellitus, Experimental/chemically induced
;
GTP-Binding Proteins/metabolism*
;
Insulin/pharmacology
;
Liver/metabolism
;
Liver/drug effects
;
Male
;
Myocardium/metabolism*
;
Protein Kinase C/metabolism
;
Rats
;
Rats, Sprague-Dawley
;
Signal Transduction
;
Streptozocin
4.Calyculin A modulates activation of the NADPH-oxidase in Me2SO-differentiated HL-60 cells.
Joo In PARK ; David J UHLINGER ; Byeung Seon CHUNG ; In Hoo KIM ; Jong Young KWAK
Experimental & Molecular Medicine 1998;30(4):214-220
Human promyelocytic leukemia cells (HL-60) have been used as a model system in which to study the effects of protein phosphatase inhibitors on NADPH-oxidase activation. Since O2- is generated by NADPH-oxidase, we examined the effect of calyculin A pretreatment on oxidase activation in response to various agonists. When Me2SO-differentiated HL-60 cells were treated with calyculin A prior to the addition of phorbol 12-myristate 13-acetate (PMA), O2- production was inhibited; however, calyculin A enhanced O2- production by N-formyl-methionyl-leucyl-phenylalanine (FMLP). The decreased O2- production seen with calyculin A pretreatment followed by PMA may be due to diminished translocation of the p47-phox and p67-phox, cytosolic components of the oxidase, and inhibition of arachidonic acid release. Interestingly calyculin A pretreatment followed by either agonist significantly enhanced mitogen-activated-protein kinase (MAPK) activity. The differential effects of pretreatment with calyculin A on subsequent oxidase stimulation elicited by FMLP or PMA provide further evidence for substantial heterogeneity in the activation of the respiratory burst.
Arachidonic Acid/metabolism
;
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism
;
Cell Differentiation
;
Dimethyl Sulfoxide/pharmacology*
;
Enzyme Inhibitors/pharmacology*
;
HL-60 Cells
;
Human
;
N-Formylmethionine Leucyl-Phenylalanine/pharmacology
;
NADPH Oxidase/metabolism*
;
Neutrophils/metabolism*
;
Neutrophils/drug effects
;
Oxazoles/pharmacology*
;
Oxygen/metabolism
;
Phosphoprotein Phosphatase/antagonists & inhibitors
;
Phosphoproteins/immunology
;
Signal Transduction
;
Tetradecanoylphorbol Acetate/pharmacology
;
Time Factors
5.Effect of serum and hydrogen peroxide on the Ca2+/calmodulin-dependent phosphorylation of eukaryotic elongation factor 2(eEF-2) in Chinese hamster ovary cells.
Experimental & Molecular Medicine 2001;33(4):198-204
Eukaryotic elongation factor eEF-2 mediates regulatory steps important for the overall regulation of mRNA translation in mammalian cells and is activated by variety of cellular conditions and factors. In this study, eEF-2 specific, Ca2+/CaM-dependent protein kinase III (CaM PK III), also called eEF-2 kinase, was examined under oxidative stress and cell proliferation state using CHO cells. The eEF-2 kinase activity was determined in the kinase buffer containing Ca2+ and CaM in the presence of eEF-2 and [gamma-32P] ATP. The eEF-2 kinase activity in cell lysates was completely dependent upon Ca2+ and CaM. Phosphorylation of eEF-2 was clearly identified in proliferating cells, but not detectable in CHO cells arrested in their growth by serum deprivation. The content of the eEF-2 protein, however, was equivalent in both cells. Using a phosphorylation state-specific antibody, we show that oxidant such as H2O2, which triggers a large influx of Ca2+, dramatically enhances the phosphorylation of eEF-2. In addition, H2O2-induced eEF-2 phosphorylation is dependent on Ca2+ and CaM, but independent of protein kinase C. In addition, okadaic acid inhibits phosphoprotein phosphatase 2A(PP2A)-mediated eEF-2 dephosphorylation. These results may provide a possible link between the elevation of intracellular Ca2+ and cell division and suggest that phosphorylation of eEF-2 is sensitive cellular reflex on stimuli that induces intracellular Ca2+ flux.
Animal
;
CHO Cells
;
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism
;
Cell Division
;
Cells, Cultured
;
Comparative Study
;
Cytosol/enzymology
;
Egtazic Acid/pharmacology
;
Hamsters
;
Human
;
Hydrogen Peroxide/*pharmacology
;
Mice
;
Okadaic Acid/pharmacology
;
Oxidants/*pharmacology
;
Peptide Elongation Factors/metabolism
;
Phosphoprotein Phosphatase/metabolism
;
Phosphorylation
;
Polyethylene Glycols/pharmacology
;
Trifluoperazine/pharmacology
6.Role of gamma-aminobutyric acid B (GABA B) receptors in the regulation of kainic acid-induced cell death in mouse hippocampus.
Han Kyu LEE ; Young Jun SEO ; Seong Soo CHOI ; Min Soo KWON ; Eon Jeong SHIM ; Jin Young LEE ; Hong Won SUH
Experimental & Molecular Medicine 2005;37(6):533-545
Kainic acid (KA) is well-known as an excitatory, neurotoxic substance. In mice, KA administered intracerebroventricularly (i.c.v.) lead to morphological damage of hippocampus expecially concentrated on the CA3 pyramidal neurons. In the present study, the possible role of gamma-aminobutyric acid B (GABA B) receptors in hippocampal cell death induced by KA (0.1 microgram) administered i.c.v. was examined. 5-Aminovaleric acid (5-AV; GABA B receptors antagonist, 20 microgram) reduced KA-induced CA3 pyramidal cell death. KA increased the phosphorylated extracellular signal-regulated kinase (p-ERK) and Ca2+ /calmodulin-dependent protein kinase II (p-CaMK II) immunoreactivities (IRs) 30 min after KA treatment, and c-Fos, c-Jun IR 2 h, and glial fibrillary acidic protein (GFAP), complement receptor type 3 (OX-42) IR 1 day in hippocampal area in KA-injected mice. 5-AV attenuated KA-induced p-CaMK II, GFAP and OX-42 IR in the hippocampal CA3 region. These results suggest that p-CaMK II may play as an important regulator on hippocampal cell death induced by KA administered i.c.v. in mice. Activated astrocytes, which was presented by GFAP IR, and activated microglia, which was presented by the OX-42 IR, may be a good indicator for measuring the cell death in hippocampal regions by KA excitotoxicity. Furthermore, it showed that GABA B receptors appear to be involved in hippocampal CA3 pyramidal cell death induced by KA administered i.c.v. in mice.
Amino Acids, Neutral/pharmacology
;
Animals
;
Ca(2+)-Calmodulin Dependent Protein Kinase/metabolism
;
Cell Death/drug effects
;
Extracellular Signal-Regulated MAP Kinases/metabolism
;
Glial Fibrillary Acidic Protein/metabolism
;
Hippocampus/anatomy & histology/*cytology/*drug effects
;
Kainic Acid/*toxicity
;
Mice
;
Mice, Inbred ICR
;
Mossy Fibers, Hippocampal/drug effects/metabolism
;
Phosphorylation/drug effects
;
Proto-Oncogene Proteins c-fos/metabolism
;
Proto-Oncogene Proteins c-jun/metabolism
;
Receptors, GABA-B/*metabolism
;
Research Support, Non-U.S. Gov't